Cargando…
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
Autores principales: | Jin, Haoli, Reed, James C., Liu, Sean T.H., Ho, Hsi-en, Lopes, Joao Pedro, Ramsey, Nicole B., Waqar, Omar, Rahman, Farah, Aberg, Judith A., Bouvier, Nicole M., Cunningham-Rundles, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490621/ https://www.ncbi.nlm.nih.gov/pubmed/32947026 http://dx.doi.org/10.1016/j.jaip.2020.08.059 |
Ejemplares similares
-
X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry
por: O’Toole, Dana, et al.
Publicado: (2022) -
Interstitial Lung Disease in Common Variable Immunodeficiency
por: Lopes, Joao Pedro, et al.
Publicado: (2021) -
A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA
por: Hernandez-Trujillo, Vivian, et al.
Publicado: (2023) -
Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia
por: Yates, Jennifer L., et al.
Publicado: (2022) -
Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
por: Tremblay, Douglas, et al.
Publicado: (2020)